Abiopharma

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

UTHR: Notification

UTHR: Notification

Citius Oncology - Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals, Inc. - Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

SeaStar Medical Announces 1-for-10 Reverse Split

Janux - Investor Relations - Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

Henry Schein Provides Update on CEO Search Process

Organogenesis Announces Initiation of Biologics License Application for ReNu®

Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study